Stock NVAX NOVAVAX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Novavax, Inc.

Equities

NVAX

US6700024010

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-09-11 EDT 		5-day change 1st Jan Change
12.29 USD -3.23% Intraday chart for Novavax, Inc. +3.54% +156.04%
09-04 Novavax Announces That Novavax COVID-19 Vaccine, Adjuvanted Receives Emergency Use Authorization from the U.S. Food and Drug Administration CI
09-02 Novavax: FDA green light for updated Covid vaccine CF

Chart calendar Novavax, Inc.

528d6c16037e1dc8031d4e98ca054f.HWReYIAvRi8amkseWQqoXJl6FHIhdE1e0ezs1dT1-PA.fC8LWPJffnBw9n50blXeN945JkFqLhxuqZ2mprGHn6osHRUt42IodkusDg~b00520670a5152783e326032fe3a18d2

Upcoming events on Novavax, Inc.

2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)
2025-08-05 Q2 2025 Earnings Release (Projected)

Past events on Novavax, Inc.

2024-09-10 15:10 Baird Global Healthcare Conference
2024-09-09 15:30 H.C. Wainwright Global Investment Conference
2024-08-08 08:30 Q2 2024 Earnings Call
2024-08-08 08:02 Q2 2024 Earnings Release
2024-06-13 08:30 Annual General Meeting
2024-06-06 12:30 Jefferies Global Healthcare Conference
2024-05-15 18:00 Bank of America Securities Health Care Conference
2024-05-10 08:30 Q1 2024 Earnings Call
2024-05-09 Q1 2024 Earnings Release Pre-market
2024-04-03 14:40 World Vaccine Congress
2024-04-03 10:25 World Vaccine Congress
2024-04-03 10:10 World Vaccine Congress
2024-03-06 13:30 TD Cowen Health Care Conference
2024-02-28 08:30 Q4 2023 Earnings Call
2024-02-28 08:00 Q4 2023 Earnings Release
2024-01-08 20:15 JPMorgan Healthcare Conference
2023-11-15 04:00 Jefferies London Healthcare Conference
2023-11-09 08:32 Q3 2023 Earnings Release
2023-11-09 08:30 Q3 2023 Earnings Call
2023-10-19 04:30 World Vaccine Congress - Perretti, A

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		1 146
1 263
-9.25%		1 982
1 947
1.77%		984
1 014
-3.03%
740


490


440

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-616
-455
-35.42%		-525
-487
-7.88%
-115


104


0,00

EBIT
Million USD		Released
Forecast
Spread 		-1 687
-979
-72.21%		-645
-480
-34.41%		-567
-424
-33.66%
-134


58,6


25,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-1 715
-1 007
-70.2%		-654
-548
-19.24%		-543
-394
-37.66%
-140


-60,5


25,5

Net income
Million USD		Released
Forecast
Spread 		-1 744
-1 021
-70.82%		-658
-548
-20.13%		-545
-413
-31.9%
-139


-13,8


34,8

EPS
USD		Released
Forecast
Spread 		-23,4
-13,7
-71.07%		-8,42
-6,98
-20.66%		-5,41
-4,22
-28.15%
-0,91


-0,02


0,31

Announcement Date28/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		735
555
32.24%		357
383
-6.72%		81,0
94,5
-14.35%		424
259
63.88%		187
96,5
93.76%		291
322
-9.51%		93,9
101
-7.49%		415
383
8.54%
59,0


168

EBITDA
Million USD		Released
Forecast
Spread 		-119
310
-138.36%











-173
-120
-43.73%		-133
-149
10.95%








EBIT
Million USD		Released
Forecast
Spread 		-127
139
-191.53%		-244
-90,2
-170.23%		-313
-278
-12.54%		55,5
-121
145.98%		-126
-223
43.74%		-184
-40,9
-348.58%		-145
-137
-5.37%		161
309
-47.83%
-168


-23,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-166
93,2
-278.36%		-185
-87,8
-110.23%		-293
-299
2.07%		57,9
-94,1
161.53%		-131
-214
38.43%		-177
-26,9
-555.91%		-145
-141
-3.03%		165
246
-33.14%
-136


-50,0

Net income
Million USD		Released
Forecast
Spread 		-169
132
-227.32%		-182
-74,2
-145.57%		-294
-291
-1.16%		58,0
-101
157.16%		-131
-217
39.77%		-178
-46,5
-283.41%		-148
-139
-6.33%		162
245
-33.8%
-136


-49,2

EPS
USD		Released
Forecast
Spread 		-2,15
1,64
-231.02%		-2,28
-1,01
-126.76%		-3,41
-3,42
0.29%		0,58
-1,16
149.81%		-1,26
-2,29
45.05%		-1,44
-0,45
-221.19%		-1,05
-1,06
1.32%		0,99
1,67
-40.71%
-0,90


-0,31

Announcement Date08/11/2228/02/2309/05/2308/08/2309/11/2328/02/2410/05/2408/08/24--

Upcoming sector events for Novavax, Inc.

2024-10-15 SYNGENE INTERNATIONAL LIMITED: Q2 2025 Earnings Release (Projected)
2024-10-20 MEDPACE HOLDINGS, INC.: Q3 2024 Earnings Release (Projected)
2024-10-22 ALKERMES PLC: Q3 2024 Earnings Release (Projected)
2024-10-22 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q3 2024 Earnings Release (Projected)
2024-10-22 SINO BIOLOGICAL,INC.: Q3 2024 Earnings Release (Projected)
2024-10-22 ICON PUBLIC LIMITED COMPANY: Q3 2024 Earnings Release (Projected)
2024-10-23 01:45 ADDLIFE AB: Q3 2024 Earnings Release
2024-10-23 R&G PHARMASTUDIES CO., LTD.: Q3 2024 Earnings Release (Projected)
2024-10-23 ALNYLAM PHARMACEUTICALS, INC.: Q3 2024 Earnings Release (Projected)
2024-10-23 BLUEPRINT MEDICINES CORPORATION: Q3 2024 Earnings Release (Projected)
More events

Past sector events for Novavax, Inc.

2024-09-09 16:01 ABIVAX: Q2 2024 Earnings Release
2024-09-05 02:00 GENUS PLC: Q4 2024 Earnings Release
2024-08-29 JOINN LABORATORIES(CHINA)CO.,LTD.: Q2 2024 Earnings Release
2024-08-29 02:00 BIOARCTIC AB: Q2 2024 Earnings Release
2024-08-28 19:27 MESOBLAST LIMITED: Q4 2024 Earnings Release
2024-08-28 R&G PHARMASTUDIES CO., LTD.: Q2 2024 Earnings Release
2024-08-28 MORPHOSYS AG: Q2 2024 Earnings Release
2024-08-28 02:00 PURETECH HEALTH PLC: Q2 2024 Earnings Release
2024-08-27 HANGZHOU TIGERMED CONSULTING CO., LTD: Q2 2024 Earnings Release
2024-08-27 04:00 OCULIS HOLDING AG: Q2 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NVAX Stock
  4. Calendar Novavax, Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition